Plain-English translation of NCT07224360 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it is safe and effective for adults with sickle cell disease. You would receive the medication as an injection under the skin over 64 weeks. The study is designed to learn whether this treatment could help reduce complications and improve quality of life for people living with sickle cell disease.
Sickle cell disease causes painful crises that send many people to the hospital. Current treatments don't work well enough for everyone, so researchers are testing this new medication to see if it offers a better option.
You likely qualify if…
You likely don't qualify if…
You would receive injections under your skin over a 64-week period. During the first 12 weeks, your dose would be gradually increased to find the right amount for your body. Then you would continue on that dose for the remaining 52 weeks. Half of participants will receive the active medication, and half will receive a placebo (inactive injection). You will have regular clinic visits to check how you are doing and watch for any side effects.
AI-generated summary from trial data · Aug 17, 2026 · Not medical advice
United States